Viewing Study NCT06334393

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2026-02-07 @ 8:36 PM
Study NCT ID: NCT06334393
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-19
First Post: 2024-03-06
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults
Sponsor: Valneva Austria GmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Zika View
None Zika Virus Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None vaccine View
None Phase 1 View